Prescient Therapeutics Ltd
ASX:PTX ISIN:AU000000PTX3
Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions.
查看其它語言版本
新聞
2011年2月14日澳洲股市報告包括：Black Fire Minerals (ASX:BFE)將收購美國內華達州已開發的Pilot Mountain鎢-銅項目的100%股份；Virax Holdings Limited (ASX:VHL)將開發一種皮膚癌新藥；Southern Cross Goldfields Limited (ASX:SXG)在西澳發現近地表高品位金礦；Prosperity Resources Limited (ASX:PSP)在印尼開始鑽探。
###
138,232 公司背景瀏覽
- 本頁瀏覽人次: (過去7日: 26) (過去30日: 97) (自發布以來: 11610)
